R&D and Innovation in Sustainable Chemistry

Company overview About Us Granules India is a vertically integrated, high-growth pharmaceutical company with 38 years of proven performance and increasing presence across the world. Headquartered in Hyderabad, India, Granules offers collaborative and strategic partnership to global pharmaceutical leaders by producing best quality API, PFI and FD through manufacturing excellence, process innovation and regulatory expertise Business Verticals Vertically integrated across value chain FD PFI ΑΡΙ Global Reach 80+ countries 300+ customers 60+ ANDA filings Top 5 products Paracetamol Metformin Ibuprofen Guaifenesin Methocarbamol Establishment in 1984 @ R&D Inaugurated a new 20,000 sqft state of the art R&D facility at Genome Valley with more than 170 scientists across both divisions Manufacturing Base 8 facilities; 6 in India, 2 in US (1 is packing unit) One of the world's largest paracetamol API facilities World's largest PFI facility One of the largest single-site FD facilities Installed Capacity 39,360 TPA of API 24,640 TPA of PFI 28.3 Bn dosages of FD Regulatory Approvals USFDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, KFDA, DEA, MCC, HALAL People Strength 5,000+ people 90+ people at GPI, Chantilly, USA 3

View entire presentation